Sermorelin

A growth hormone-releasing hormone analogue historically used in specific clinical diagnostic and treatment contexts.

Commonly discussed or studied in relation to:

It is frequently discussed in longevity clinics and media in relation to age-related changes in growth hormone signalling.

Human research exists mainly in specific clinical contexts rather than for general wellness or anti-aging goals.

Human research: Human studies available.

Historic approvals and current availability differ by country and over time; wellness or anti-aging uses are generally not approved uses.

Approval for one specific indication never implies approval or suitability for wellness, cosmetic, or anti-aging uses.

• It acts on established endocrine pathways studied in clinical medicine.
• Clinical research has focused on defined medical scenarios.

• Long-term outcomes when used for general anti-aging goals.
• Whether hormonal changes seen in studies translate to meaningful everyday differences.

• Hormone-related interventions require clinical oversight and monitoring.
• Marketing in the longevity space often outpaces the published evidence.

• What evidence supports this peptide for the goal I'm interested in?
• Is this peptide approved for this particular use?
• What benefits are supported by human evidence?
• What risks or side effects should I understand?
• What important unknowns remain?

• Overview literature relating to sermorelin

  Placeholder — reputable reference to be added · Pending review

• Regulatory status information

  Placeholder — official regulatory source to be added · Pending review

Last reviewed: 2026-08-01